Syra Health Corp.
SYRA
$0.17
$0.0431.54%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.23M | 7.50M | 8.06M | 8.09M | 7.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.23M | 7.50M | 8.06M | 8.09M | 7.98M |
| Cost of Revenue | 4.74M | 5.27M | 5.72M | 6.15M | 6.33M |
| Gross Profit | 2.49M | 2.23M | 2.35M | 1.94M | 1.65M |
| SG&A Expenses | 3.30M | 3.41M | 3.67M | 4.33M | 4.77M |
| Depreciation & Amortization | 20.50K | 25.50K | 45.60K | 57.00K | 62.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.13M | 8.77M | 9.53M | 10.88M | 11.75M |
| Operating Income | -904.40K | -1.27M | -1.47M | -2.79M | -3.77M |
| Income Before Tax | -896.40K | -1.27M | -1.46M | -2.78M | -3.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.90 | -1.27 | -1.46 | -2.78 | -3.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -896.40K | -1.27M | -1.46M | -2.78M | -3.76M |
| EBIT | -904.40K | -1.27M | -1.47M | -2.79M | -3.77M |
| EBITDA | -880.80K | -1.24M | -1.42M | -2.74M | -3.70M |
| EPS Basic | -0.08 | -0.12 | -0.15 | -0.36 | -0.54 |
| Normalized Basic EPS | -0.05 | -0.07 | -0.10 | -0.23 | -0.34 |
| EPS Diluted | -0.08 | -0.12 | -0.15 | -0.36 | -0.54 |
| Normalized Diluted EPS | -0.05 | -0.07 | -0.10 | -0.23 | -0.34 |
| Average Basic Shares Outstanding | 47.41M | 45.30M | 40.63M | 35.29M | 30.20M |
| Average Diluted Shares Outstanding | 47.41M | 45.30M | 40.63M | 35.29M | 30.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |